ScientiaCME

ScientiaCME CME Courses

Format: Online Publication
Price: Free
Release Date: 9/19/2017
Expiration Date: 9/19/2019
Summary:

Learning Objectives:

  • Summarize the most impactful findings presented at ASCO 2017 relating to Metastatic Melanoma and apply them to patient cases, taking into account any relevant barriers to care.
  • Additional objectives to be dictated by clinical content
Format: Online Streaming Video
Price: Free
Release Date: September 04, 2017
Expiration Date: September 04, 2019
Summary:
This is an online CME self-learning program.

Rheumatoid arthritis (RA) is a systemic autoimmune disorder in which joints, typically those in the hands and feet, become inflamed, swollen, painful, and stiff. Without appropriate treatment, the inflammation may become chronic and cause irreversible destruction of bone and cartilage in the affected joints as well as contribute to the development of clinically important co-morbid conditions with attendant morbidity and mortality. The National Arthritis Data Workgroup estimates that about 1.3 million U.S. adults (0.6% of the adult population) have RA. RA imposes a considerable disease burden. Patients with RA have substantially lower health-related quality of life (QOL) than the general population with lower overall scores for physical and mental health across all age groups.The RA disease burden also is associated with increased health care resource utilization. Notably, RA patients with low QOL are twice as likely to be hospitalized as RA patients with high QOL.

Some have suggested that criteria used for the past two decades are inadequate for addressing the disease burden of RA because by the time a physician detects rheumatoid nodules or radiographic erosion, the optimal time has passed for treatment initiation, representing a gap in care relating to diagnosis of disease. Another potential gap is illustrated by studies in which researchers demonstrated that a systematic, objective approach to therapy with Disease Activity Score-driven therapy yields superior outcomes to routine care.

By the end of the session the participant will be able to:

  • Describe the pathophysiology of RA such that it might inform treatment mechanisms.
  • Describe professional guideline recommendations’ approaches to the diagnosis and treatment of RA and, where applicable, apply them to patient cases
  • Identify the currently available and emerging pharmacotherapeutic treatments for management of RA and apply them to patient cases using evidence-based medicine.
  • Evaluate a treatment plan for a specific patient with RA to optimize safety and efficacy, suggesting modifications for improvement, including the management of comorbidities.
  • Describe the challenges and barriers to care associated with treating patients with RA.

Format: Online Streaming Video
Price: Free
Summary:

Seven lectures from ScientiaCME covering various psychiatry and neuropsychiatry topics, including:

  • ADHD: Therapeutic Updates and Best Practices - released 7/01/2013 (1 CME Hour)
  • Alzheimer Disease andIts Complications: Therapeutic Updates, Best Practices, and Barriers to Care - released 12/21/2015 (1 CME Hour)
  • Bipolar disorder: Therapeutic Updates and Best Practices - released 10/1/2015 (0.75 CME hours)
  • Treatment and Management of Schizophrenia: Barriers to Care, Therapeutic Updates, and Best Practices - released 4/29/2016 (1 CME Hour)
  • Therapeutic Updates and Best Practices in the Treatment of Major Depressive Disorders (MDD) - released 4/12/2016 - (1 CME Hour)
  • Transcendental Medication Techniquest to Treat and Prevent Stress-Related Disorders - released 2/8/2016 (1 CME Hour)
  • Therapeutic Updates, Barriers to Care, and Best Practices in the Treatment of Schizophrenia - released 12/27/2014 (1 CME Hour)

Share This